Clinical Trial

Chinese FPD Registry

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the Chinese Familial Parkinson's disease Registry (CFPDR) is to develop a database of patients with familial Parkinson's disease (PD) in China.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-04-24.
Trial Details
NCT Number NCT03508986
Lead Sponsor Xiangya Hospital of Central South University
Conditions Parkinson Disease
Enrollment 1,500 participants
Start Date 2017-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2018-05-11